Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery

Background: Axillary lymph node dissection (ALND) in breast cancer management, necessitates a nuanced understanding of complications that may impede treatment progression. This study scrutinize the impact of Haemoblock hemostatic solution, evaluation it's potential in reducing seroma complicati...

Full description

Bibliographic Details
Published in:World Journal of Surgery
Main Author: Isahak M.I.; Abdullah M.S.; Awang R.R.; Abdul Rashid N.F.; Md Sikin S.; Abdullah Suhaimi S.N.; Abdullah N.; Muhammad R.; Md Latar N.H.
Format: Article
Language:English
Published: John Wiley and Sons Inc 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85190371639&doi=10.1002%2fwjs.12134&partnerID=40&md5=dbe42b10fa9f4eb2aee613bf8590be13
id 2-s2.0-85190371639
spelling 2-s2.0-85190371639
Isahak M.I.; Abdullah M.S.; Awang R.R.; Abdul Rashid N.F.; Md Sikin S.; Abdullah Suhaimi S.N.; Abdullah N.; Muhammad R.; Md Latar N.H.
Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
2024
World Journal of Surgery
48
5
10.1002/wjs.12134
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85190371639&doi=10.1002%2fwjs.12134&partnerID=40&md5=dbe42b10fa9f4eb2aee613bf8590be13
Background: Axillary lymph node dissection (ALND) in breast cancer management, necessitates a nuanced understanding of complications that may impede treatment progression. This study scrutinize the impact of Haemoblock hemostatic solution, evaluation it's potential in reducing seroma complication by controlling lymph flow and obliterating axillary dead space. Method: A prospective, randomized, double-blinded controlled trial was conducted with 58 patients undergoing breast conserving surgery (BCS) and ALND, stratified into two groups: Group A (ALND + Haemoblock, n = 29) and Group B (ALND + placebo, n = 29). Postoperative drainage charts were monitored, with the primary endpoint being the time to drain removal, Additionally, patients were observed for surgical site infection (SSI). Results: Group A exhibited a marginally higher mean total drain output (398 +/− 205 vs. 326 +/− 198) compared to Group B, this difference did not attain statistical significance (p = 0.176). Equally, the mean time to drain removal demonstrated no discernible distinction between the two groups (6 +/− 3.0 vs. 6 +/− 3.0, Group A vs. Group B, p = 0.526). During follow up, nine patients in Group A required seroma aspiration (mean aspiration 31 +/− 73) as compared to Group B, 6 patients required aspiration (mean aspiration 12 +/− 36), p = 0.222). No notable disparity in SSI rates between the groups was identified. Conclusion: In conclusion, the administration of Haemoblock did not manifest a discernible effect in mitigating seroma production, hastening drain removal, or influencing SSI rates following ALND. The study underscores the intricate and multifactorial nature of seroma formation, suggesting avenues for future research to explore combined interventions and protracted follow-up periods for a more comprehensive understanding. © 2024 International Society of Surgery/Société Internationale de Chirurgie (ISS/SIC).
John Wiley and Sons Inc
3642313
English
Article

author Isahak M.I.; Abdullah M.S.; Awang R.R.; Abdul Rashid N.F.; Md Sikin S.; Abdullah Suhaimi S.N.; Abdullah N.; Muhammad R.; Md Latar N.H.
spellingShingle Isahak M.I.; Abdullah M.S.; Awang R.R.; Abdul Rashid N.F.; Md Sikin S.; Abdullah Suhaimi S.N.; Abdullah N.; Muhammad R.; Md Latar N.H.
Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
author_facet Isahak M.I.; Abdullah M.S.; Awang R.R.; Abdul Rashid N.F.; Md Sikin S.; Abdullah Suhaimi S.N.; Abdullah N.; Muhammad R.; Md Latar N.H.
author_sort Isahak M.I.; Abdullah M.S.; Awang R.R.; Abdul Rashid N.F.; Md Sikin S.; Abdullah Suhaimi S.N.; Abdullah N.; Muhammad R.; Md Latar N.H.
title Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
title_short Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
title_full Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
title_fullStr Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
title_full_unstemmed Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
title_sort Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
publishDate 2024
container_title World Journal of Surgery
container_volume 48
container_issue 5
doi_str_mv 10.1002/wjs.12134
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85190371639&doi=10.1002%2fwjs.12134&partnerID=40&md5=dbe42b10fa9f4eb2aee613bf8590be13
description Background: Axillary lymph node dissection (ALND) in breast cancer management, necessitates a nuanced understanding of complications that may impede treatment progression. This study scrutinize the impact of Haemoblock hemostatic solution, evaluation it's potential in reducing seroma complication by controlling lymph flow and obliterating axillary dead space. Method: A prospective, randomized, double-blinded controlled trial was conducted with 58 patients undergoing breast conserving surgery (BCS) and ALND, stratified into two groups: Group A (ALND + Haemoblock, n = 29) and Group B (ALND + placebo, n = 29). Postoperative drainage charts were monitored, with the primary endpoint being the time to drain removal, Additionally, patients were observed for surgical site infection (SSI). Results: Group A exhibited a marginally higher mean total drain output (398 +/− 205 vs. 326 +/− 198) compared to Group B, this difference did not attain statistical significance (p = 0.176). Equally, the mean time to drain removal demonstrated no discernible distinction between the two groups (6 +/− 3.0 vs. 6 +/− 3.0, Group A vs. Group B, p = 0.526). During follow up, nine patients in Group A required seroma aspiration (mean aspiration 31 +/− 73) as compared to Group B, 6 patients required aspiration (mean aspiration 12 +/− 36), p = 0.222). No notable disparity in SSI rates between the groups was identified. Conclusion: In conclusion, the administration of Haemoblock did not manifest a discernible effect in mitigating seroma production, hastening drain removal, or influencing SSI rates following ALND. The study underscores the intricate and multifactorial nature of seroma formation, suggesting avenues for future research to explore combined interventions and protracted follow-up periods for a more comprehensive understanding. © 2024 International Society of Surgery/Société Internationale de Chirurgie (ISS/SIC).
publisher John Wiley and Sons Inc
issn 3642313
language English
format Article
accesstype
record_format scopus
collection Scopus
_version_ 1809678153537290240